Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Joseph M. Chan, Samir Zaidi, Jillian Love, et al.
Science (2022) Vol. 377, Iss. 6611, pp. 1180-1191
Open Access | Times Cited: 202

Showing 26-50 of 202 citing articles:

Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
Sheng‐Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 12
Genetically-engineered mouse models of small cell lung cancer: the next generation
Matthew G. Oser, David MacPherson, Trudy G. Oliver, et al.
Oncogene (2024)
Open Access | Times Cited: 11
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression
Tingting Zhang, Faming Zhao, Yahang Lin, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1065-1080
Open Access | Times Cited: 11
Organoid bioinks: construction and application
Fuxiao Wang, Peiran Song, Jian Wang, et al.
Biofabrication (2024) Vol. 16, Iss. 3, pp. 032006-032006
Open Access | Times Cited: 11
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
Salomon Tendler, Mark Dunphy, Matthew Agee, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. 1015-1024
Closed Access | Times Cited: 11
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1336-1351.e9
Open Access | Times Cited: 11
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 11
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer
Yaru Xu, Yuqiu Yang, Zhaoning Wang, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1496-1521
Open Access | Times Cited: 10
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies
Samir Zaidi, Jooyoung Park, Joseph M. Chan, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 28
Open Access | Times Cited: 9
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
Rodrigo Romero, Tinyi Chu, Tania J. González-Robles, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1641-1659
Open Access | Times Cited: 9
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression
Duminduni H. Angappulige, Nupam P. Mahajan, Kiran Mahajan
Trends in cancer (2024) Vol. 10, Iss. 4, pp. 369-381
Open Access | Times Cited: 8
Allele-specific transcriptional effects of subclonal copy number alterations enable genotype-phenotype mapping in cancer cells
Hongyu Shi, Marc Williams, Gryte Satas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
Chen Qian, Qian Yang, Mirja Rotinen, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7740-7760
Open Access | Times Cited: 8
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer
Leslie Duplaquet, Kevin Kam Fung So, Alexander W. Ying, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1352-1369.e13
Open Access | Times Cited: 8
Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis
Siyuan Cheng, Lin Li, Yunshin Yeh, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Epigenomic heterogeneity as a source of tumour evolution
Marthe Laisné, Mathieu Lupien, Céline Vallot
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
LKB1 inactivation promotes epigenetic remodeling-induced lineage plasticity and antiandrogen resistance in prostate cancer
Fei Li, Pengfei Dai, Huili Shi, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 59-71
Open Access | Times Cited: 1
Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer
Slim Mzoughi, Megan Schwarz, Xuedi Wang, et al.
Nature Genetics (2025)
Open Access | Times Cited: 1
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
Tomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access | Times Cited: 1
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
Hanling Wang, Sulin Zhang, Qiang Pan‐Hammarström, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
Prostate organoids: emerging experimental tools for translational research
Michael L. Beshiri, Supreet Agarwal, Juan Juan Yin, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 19
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer
Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 722
Open Access | Times Cited: 17
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A
Manjunath Siddappa, Shahid Hussain, Sajad A. Wani, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 4, pp. 621-639
Open Access | Times Cited: 16
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
Zifeng Wang, Scott L. Townley, Songqi Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
Zhen Qin, Meiting Yue, Shijie Tang, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 3
Open Access | Times Cited: 6

Scroll to top